Choueiri Reflects on Recent RCC Advances
Toni K. Choueiri, MD reflects on recent RCC advances.07/27/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 27, 2018 Category: Urology & Nephrology Source Type: news

30 Simple Ways You Can Prevent Cancer
People who eat broccoli and its cousins such as cabbage, cauliflower and bok choy at least once per week have a lower risk of kidney cancer compared with people who consume them less than once a month, according to a multinational European study.07/27/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 27, 2018 Category: Urology & Nephrology Source Type: news

Patients With Early Kidney Cancer Benefit From Robotic Partial Nephrectomy
A comprehensive study by the Keck School of Medicine of USC, which has found that robotic partial nephrectomy offers significantly better patient outcomes.07/26/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 26, 2018 Category: Urology & Nephrology Source Type: news

mRCC: Cytoreductive Nephrectomy in the Modern Era
Walter Stadler, M.D., who is on our medical steering committee, is one of the panelists in this video.07/26/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 26, 2018 Category: Urology & Nephrology Source Type: news

Good results seen with laparoscopic partial nephrectomy following selective embolization of tumor
The short-term oncological and functional outcomes for partial nephrectomy are comparable for laparoscopic partial nephrectomy following selective embolization of tumor (LPNE) in a hybrid operating room and robot-assisted partial nephrectomy (RAPN). A longer follow-up and a larger cohort of patients would be necessary to verify the benefits of LPNE, which appears to be a very interesting alternative to RAPN.07/25/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 25, 2018 Category: Urology & Nephrology Source Type: news

Poorer RCC outcomes with incidental upstaging after partial nephrectomy
Patients with incidental pathologic T3a (pT3a) upstaging after partial nephrectomy (PN) have significantly reduced recurrence-free survival (RFS) and cancer-specific survival (CSS) when compared to patients whose disease isn't upstages from pT1a-b.07/25/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 25, 2018 Category: Urology & Nephrology Source Type: news

Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis
Treatment of patients with metastatic renal cell carcinoma (mRCC) and end-stage renal disease (ESRD) on dialysis poses a therapeutic challenge, particularly as this patient group was excluded from the pivotal clinical trials. In addition, there is uncertainty regarding drug dosing/pharmacokinetics, lack of safety and efficacy data, and potential for increased toxicity when using targeted therapy or immunotherapy for the management of patients with mRCC on dialysis.07/25/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 25, 2018 Category: Urology & Nephrology Source Type: news

Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is the main subtype of malignant kidney cancer. Long non ‑coding RNA (lncRNA) serves a key role in predicting survival in patients with cancer.07/25/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 25, 2018 Category: Urology & Nephrology Source Type: news

Rise in Localized High-Risk RCC Reported
Over a 25-year period, the proportion of patients with high-risk clinical T1 tumors increased by nearly 20 percent and clinical tumor size decreased from 8.4 to 6.2 cm, an Italian study found.07/24/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 24, 2018 Category: Urology & Nephrology Source Type: news

Diabetic women at greater risk of developing cancer
Women with diabetes have an 11 percent higher chance of developing kidney cancer.07/20/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 23, 2018 Category: Urology & Nephrology Source Type: news

VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Studies show that ZHX2 could be used as a potential therapeutic target for ccRCC.07/20/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 23, 2018 Category: Urology & Nephrology Source Type: news

Only 16% of those most at risk of bladder and kidney cancer check for this one vital sign
Blood in urine is a key symptom of kidney cancer.07/19/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 23, 2018 Category: Urology & Nephrology Source Type: news

Renal cell cancer risk after kidney transplantation
This study shows the risk of RCC after kidney transplantation.07/19/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 19, 2018 Category: Urology & Nephrology Source Type: news

Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
In a study reported in JAMA Oncology, Carlo et al found a high prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma (RCC).07/19/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 19, 2018 Category: Urology & Nephrology Source Type: news

Acute Kidney Injury in Patients With Cancer
Acute kidney injury (AKI) is a common complication in cancer patients and occurs in up to 30% of patients during their disease course. Multiple myeloma, leukemia/lymphoma, renal cell carcinoma, and hematopoietic stem cell transplantation are commonly associated with the development of AKI.07/19/2018 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - July 19, 2018 Category: Urology & Nephrology Source Type: news